Cardiff Oncology Inc.

NASDAQ: CRDF · Real-Time Price · USD
2.44
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
2.43
-0.21%
After-hours: Aug 15, 2025, 04:07 PM EDT

Cardiff Oncology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-51.02M -48.85M -45.43M -42.98M -40.86M -40.23M -41.44M -40.8M -39.64M -38.93M -38.7M -39.45M -37.79M -34.1M -28.29M -25.45M -23.03M -20.4M
Depreciation & Amortization
654K 530K 404K 411K 417K 410K 398K 381K 355K 295K 236K 263K 292K 363K 451K 455.26K 460.1K 465.69K
Stock-Based Compensation
5.5M 5M 4.76M 4.46M 4.17M 4.57M 4.51M 4.61M 4.69M 4.17M 4.26M 4.23M 4.14M 4.12M 3.23M 3.19M 2.61M 1.86M
Other Working Capital
-282K 494K 1.57M 4.43M 4.98M 5.18M 6.57M 312K -620K -415K -2.73M -389K -1.22M -2.3M -1.39M -780.08K 44.87K -908.92K
Other Non-Cash Items
3.25M 195K 194K -21.29M -11.4M -896K -921K 20.68M 11.06M 124K 772K 1.34M 1.8M 2.14M 2.03M -42.15M -42.37M -42.7M
Deferred Income Tax
n/a n/a n/a 21.43M 11.39M n/a n/a -21.43M -11.39M n/a n/a 442K 892K 1.32M 1.32M 44.87M 44.56M 44.21M
Change in Working Capital
-236K 1.16M 3.17M 4.18M 5.01M 6.2M 6.57M 3.42M 2.25M 2.12M -380K 1.35M 869K -1.24M -1.79M -1.68M -1.06M -2.25M
Operating Cash Flow
-41.84M -42.75M -37.69M -34.56M -32.07M -29.97M -30.89M -33.14M -32.67M -32.23M -33.82M -31.82M -29.8M -27.41M -23.04M -20.77M -18.83M -18.82M
Capital Expenditures
-26K n/a -80K -88K -403K -654K -582K -649K -782K -843K -1.01M -1.04M -688K -376K -205K -156.1K -212.1K -212.1K
Cash Acquisitions
n/a n/a n/a 6.77M 7.09M 7.34M n/a -13.87M -14.18M -14.43M -7.09M -98K -98K -98K -98K n/a n/a n/a
Purchase of Investments
-78.44M -57.55M -23.56M -26.16M -20.14M -33.68M -70.08M -78.3M -84.79M -91.79M -91.23M -108.18M -89.75M -96.96M -174.38M -146.63M -141.95M -114.19M
Sales Maturities Of Investments
53.98M 52.96M 37.37M 49.02M 56.57M 67.83M 106.86M 108.6M 116.53M 119.64M 130.27M 131.44M 115.58M 95.95M 43.14M 24.08M 11.24M 2.5M
Other Investing Acitivies
n/a 13.11M 18.73M 11.96M 11.64M -2.62M n/a 13.87M 14.22M 14.55M 25.74M 18.74M 18.6M -476K -130.7M -130.65M -130.7M -111.7M
Investing Cash Flow
-24.49M -5.49M 13.73M 22.78M 36.03M 33.5M 36.2M 29.65M 31M 27.12M 38.15M 22.34M 25.22M -1.39M -131.45M -122.71M -130.91M -111.91M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
-6K -12K -12K -24K -24K -24K -24K -426K -426K -426K -432K -42K -36K -30K -30K -6K -6K -6K
Other Financial Acitivies
7.45M 9.51M 9.61M 9.6M 2.17M 119K 12K 426K 495K 495K 501K 87K 12K 6K 1.26M 101.02M 113.35M 118.32M
Financial Cash Flow
51.62M 53.68M 53.78M 9.6M 2.17M 107K n/a -12K 69K 69K 63K 15.03M 14.95M 34.18M 35.45M 120.25M 132.57M 136.12M
Net Cash Flow
-14.72M 5.44M 29.82M -2.19M 6.13M 3.64M 5.31M -3.48M -1.6M -5.04M 4.4M 5.55M 10.38M 5.39M -119.04M -23.24M -17.17M 5.38M
Free Cash Flow
-41.87M -42.75M -37.77M -34.65M -32.47M -30.62M -31.47M -33.79M -33.45M -33.07M -34.83M -32.86M -30.49M -27.78M -23.25M -20.93M -19.05M -19.04M